Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05752799Active, not recruiting
Randomised, double-blind trial of magnesium sulfate, dexmedetomidine, ketamine and Lidocaine Hydrochloride Injection, without epinephrine in pain (2 arms), sponsored by G. Gennimatas General Hospital. Primary endpoint: Postoperative Visual Analogue Scale score at 6 hours. Started Jan 2023; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05752799.